Startup Sirnaomics Takes Aim at Phase I in China in ’08 Even as It Looks to Raise Cash

The company, which was founded six months ago by Intradigm co-founder Patrick Lu, thinks it can achieve its goal of launching a phase I trial next year by running the study in China where regulators are more willing to sign off on human testing than the US Food and Drug Administration.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.